Manabu Satani

699 total citations
19 papers, 500 citations indexed

About

Manabu Satani is a scholar working on Hepatology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Manabu Satani has authored 19 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 5 papers in Surgery and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Manabu Satani's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer Mechanisms and Therapy (4 papers). Manabu Satani is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer Mechanisms and Therapy (4 papers). Manabu Satani collaborates with scholars based in Japan, United States and France. Manabu Satani's co-authors include Masahito Nakano, Takuji Torimura, Ryoko Kuromatsu, Shusuke Okamura, Shuji Sumie, Michio Sata, Takashi Niizeki, Shingo Yamada, Shigeo Shimose and Atsushi Kawaguchi and has published in prestigious journals such as PLoS ONE, Annals of Surgical Oncology and Oncotarget.

In The Last Decade

Manabu Satani

19 papers receiving 496 citations

Peers

Manabu Satani
Lei Yin China
Luwen Mu China
Aaron C. Haran United States
Bai Sun China
Dawn Q. Chong Singapore
Phillip M. Garfin United States
Lei Yin China
Manabu Satani
Citations per year, relative to Manabu Satani Manabu Satani (= 1×) peers Lei Yin

Countries citing papers authored by Manabu Satani

Since Specialization
Citations

This map shows the geographic impact of Manabu Satani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manabu Satani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manabu Satani more than expected).

Fields of papers citing papers by Manabu Satani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manabu Satani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manabu Satani. The network helps show where Manabu Satani may publish in the future.

Co-authorship network of co-authors of Manabu Satani

This figure shows the co-authorship network connecting the top 25 collaborators of Manabu Satani. A scholar is included among the top collaborators of Manabu Satani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manabu Satani. Manabu Satani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Iwamoto, Hideki, Takashi Niizeki, Shigeo Shimose, et al.. (2019). Dose and Location of Irradiation Determine Survival for Patients with Hepatocellular Carcinoma with Macrovascular Invasion in External Beam Radiation Therapy. Oncology. 96(4). 192–199. 5 indexed citations
2.
Shirono, Tomotake, Hideki Iwamoto, Takashi Niizeki, et al.. (2018). Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma. Oncology. 96(2). 79–86. 11 indexed citations
4.
Okamura, Shusuke, Shuji Sumie, Tatsuyuki Tonan, et al.. (2016). Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma. Digestive and Liver Disease. 48(8). 945–952. 37 indexed citations
5.
Nagamatsu, Hiroaki, Shuji Sumie, Takashi Niizeki, et al.. (2016). Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study. Cancer Chemotherapy and Pharmacology. 77(2). 243–250. 19 indexed citations
6.
Aino, Hajime, Shuji Sumie, Takashi Niizeki, et al.. (2016). The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis. Molecular and Clinical Oncology. 5(1). 83–88. 28 indexed citations
7.
Nakano, Masahito, Masatoshi Tanaka, Ryoko Kuromatsu, et al.. (2016). Alternative treatments in advanced hepatocellular carcinoma patients with progressive disease after sorafenib treatment: a prospective multicenter cohort study. Oncotarget. 7(39). 64400–64409. 5 indexed citations
8.
Nakano, Masahito, Masatoshi Tanaka, Ryoko Kuromatsu, et al.. (2015). Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study. Cancer Medicine. 4(12). 1836–1843. 46 indexed citations
9.
Kawaguchi, Takumi, Masahito Nakano, Manabu Satani, et al.. (2014). Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases. Oncology Letters. 7(6). 2130–2134. 3 indexed citations
10.
Sumie, Shuji, Takumi Kawaguchi, Atsushi Kawaguchi, et al.. (2014). Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study. Molecular and Clinical Oncology. 3(1). 115–120. 13 indexed citations
11.
Aino, Hajime, Shuji Sumie, Takashi Niizeki, et al.. (2014). Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis. Molecular and Clinical Oncology. 2(3). 393–398. 55 indexed citations
12.
Nakano, Masahito, Takumi Kawaguchi, Shingo Nakamoto, et al.. (2013). Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection. Oncology Reports. 30(5). 2049–2055. 4 indexed citations
13.
Sumie, Shuji, Osamu Nakashima, Koji Okuda, et al.. (2013). The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma. Annals of Surgical Oncology. 21(3). 1002–1009. 157 indexed citations
14.
Yamada, Shingo, Atsushi Kawaguchi, Takumi Kawaguchi, et al.. (2013). Serum albumin level is a notable profiling factor for non‐B, non‐C hepatitis virus‐related hepatocellular carcinoma: A data‐mining analysis. Hepatology Research. 44(8). 837–845. 24 indexed citations
15.
Sumie, Shuji, Takumi Kawaguchi, Ryoko Kuromatsu, et al.. (2011). Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection. PLoS ONE. 6(11). e26840–e26840. 30 indexed citations
16.
Tanaka, E., Shigeru Tsuji, Yoshinaka Murai, et al.. (2005). Neuroprotective mechanisms of lidocaine against in vitro ischemic insult of the rat hippocampal CA1 pyramidal neurons. Neuroscience Research. 53(3). 271–278. 18 indexed citations
17.
Satani, Manabu, et al.. (2003). Expression and characterization of human bifunctional peptidylglycine α-amidating monooxygenase. Protein Expression and Purification. 28(2). 293–302. 15 indexed citations
18.
Takahashi, Kenichi, et al.. (2002). Expression and characterization of frog peptidylglycine α-hydroxylating monooxygenase. Protein Expression and Purification. 27(1). 35–41. 3 indexed citations
19.
Takahashi, Kenichi, Manabu Satani, Yun Gao, & Masato Noguchi. (2002). The reaction mechanism of peptidylglycine α-hydroxylating monooxygenase. International Congress Series. 1233. 235–240. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026